PolyNovo Limited
PNV
Rank in Stocks
#12978
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices... PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Share Price
$0.61604912
Last synced: 2026-11-10
Market Cap
$425.59M
Change (1 day)
-1.66%
Change (1 year)
-21.44%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PolyNovo Limited (PNV)
Category
Healthcare
Operating Margin for PolyNovo Limited (PNV)
Operating Margin as of November 2026 TTM: 4.99%
According to PolyNovo Limited's latest financial reports, its current operating margin (TTM) is 4.99%. At the end of 2025 the company had an operating margin of 3.52%.
Operating Margin history for PolyNovo Limited from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 4.99% | 41.76% |
| 2025 | 3.52% | 211.50% |
| 2024 | 1.13% | -111.92% |
| 2023 | -9.48% | 1,429.03% |
| 2022 | -0.62% | -97.40% |
| 2021 | -23.86% | 27.66% |
| 2020 | -18.69% | -57.41% |
| 2019 | -43.88% | -59.43% |
| 2018 | -108.16% | -23.90% |
| 2017 | -142.13% | 6.50% |
| 2016 | -133.45% | -99.25% |
| 2015 | -17,767.13% | 159.91% |
| 2014 | -6,836.00% | 124.87% |
| 2013 | -3,040.02% | 80.44% |
| 2012 | -1,684.77% | 68.87% |
| 2011 | -997.68% | -62.34% |
| 2010 | -2,649.50% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | -100.00% |
| 2007 | -339,876.32% | -95.19% |
| 2006 | -7,069,101.12% | 0.00% |
| 2005 | 0.00% | -100.00% |
| 2004 | -1,478,588.52% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2001 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -96.95% |
US
|
|
| 18.08% | -96.38% |
IE
|
|
| 21.25% | -95.74% |
US
|
|
| 21.05% | -95.78% |
US
|
|
| 28.09% | -94.37% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about PolyNovo Limited's operating margin
What is PolyNovo Limited's operating margin?
PolyNovo Limited's operating margin is 4.99%, as of Nov 2026.
What was PolyNovo Limited's operating margin in 2025?
In 2025, PolyNovo Limited's operating margin was 3.52%, compared with 1.13% in 2024.
How has PolyNovo Limited's operating margin changed since 2020?
From 2020 to 2025, PolyNovo Limited's operating margin was highest in 2025 (3.52%) and lowest in 2021 (-23.86%).
How does PolyNovo Limited's operating margin compare with similar companies?
PolyNovo Limited's operating margin (4.99%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.